Antonios Keramopoulos - Publications, H-index & Citations

Antonios Keramopoulos

Alexandra Hospital

24H指数

68论文数

1.4K被引数

收录论文 19

发表时间

Germline mutations in a clinic-based series of pregnancy associated breast cancer patients

BMC CANCER

IF3.4

2021-05-19

OAAI

Zografos, Eleni; Korakiti, Anna-Maria; Andrikopoulou, Angeliki; Rellias, Ioannis; Dimitrakakis, Constantine; Marinopoulos, Spyridon; Giannos, Aris; Keramopoulos, Antonios; Bredakis, Nikolaos; Dimopoulos, Meletios-Athanasios; Zagouri, Flora

Different genomic rearrangements account for 17% of BRCA1/2 mutations in Greece

CANCER RESEARCH

IF16.6

2015-05-01

PREAI

Apessos, Angela; Papadopoulou, Eirini; Metaxa-Mariatou, Vassiliki; Agiannitopoulos, Konstantinos; Markopoulos, Christos; Venizelos, Vasileios; Xepapadakis, Grigorios; Vasilaki-Antonatou, Maria; Keramopoulos, Antonios; Bredakis, Nikolaos; Tsiftsoglou, Aristeidis; Kesisis, Georgios; Kakolyris, Stylianos; Touroutoglou, Nikolaos; Natsiopoulos, Ioannis; Papazisis, Konstantinos; Nasioulas, Georgios

Y-box-binding protein 1 (YB1) in breast carcinomas: Relation to aggressive tumor phenotype and identification of patients at high risk for relapse

EJSO

IF2.9

2014-03-01

PREAI

Mylona, E.; Melissaris, S.; Giannopoulou, I.; Theohari, I.; Papadimitriou, C.; Keramopoulos, A.; Nakopoulou, L.

An immunohistochemical evaluation of the proteins Wnt1 and glycogen synthase kinase (GSK)-3β in invasive breast carcinomas

HISTOPATHOLOGY

IF4.1

2013-06-28

OAAI

Mylona, Eleni; Vamvakaris, Ioannis; Giannopoulou, Ioanna; Theohari, Irene; Papadimitriou, Christos; Keramopoulos, Antonios; Nakopoulou, Lydia

Greek BRCA1 and BRCA2 mutation spectrum:: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients

BREAST CANCER RESEARCH AND TREATMENT

IF3

2007-04-24

PREAI

Konstantopoulou, Irene; Rampias, Theodore; Ladopoulou, Angela; Koutsodontis, George; Armaou, Sophia; Anagnostopoulos, Theodore; Nikolopoulos, George; Kamakari, Smaragda; Nounesis, George; Stylianakis, Antonis; Karanikiotis, Charisios; Razis, Evangelia; Gogas, Helen; Keramopoulos, Antonios; Gaki, Vassiliki; Markopoulos, Christos; Skarlos, Dimosthenis; Pandis, Nikos; Bei, Thalia; Arzimanoglou, Iordanis; Fountzilas, George; Yannoukakos, Drakoulis

Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma

EJSO

IF2.9

2007-04-01

PREAI

Mylona, E.; Alexandrou, P.; Mpakali, A.; Giannopoulou, I.; Liapis, G.; Markaki, S.; Keramopoulos, A.; Nakopoulou, L.

The clinicopathological and prognostic significance of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-9 according to their localization in invasive breast carcinoma

HISTOPATHOLOGY

IF4.1

2007-01-25

PREAI

Mylona, E.; Nomikos, A.; Magkou, C.; Kamberou, M.; Papassideri, I.; Keramopoulos, A.; Nakopoulou, L.

Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: Relation to tumor phenotype and clinical outcome

BREAST CANCER RESEARCH

IF5.6

2006-10-10

OAAI

Mylona, Eleni; Magkou, Christina; Giannopoulou, Ioanna; Agrogiannis, George; Markaki, Sofia; Keramopoulos, Antonios; Nakopoulou, Lydia

Study of phospho-β-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcome

MODERN PATHOLOGY

IF5.5

2006-01-01

OAAI

Nakopoulou, L; Mylona, E; Papadaki, I; Kavantzas, N; Giannopoulou, I; Markaki, S; Keramopoulos, A

Overexpression of cyclooxygenase-2 is associated with a favorable prognostic phenotype in breast carcinoma

PATHOBIOLOGY

IF2

2005-12-21

PREAI

Nakopoulou, L; Mylona, E; Papadaki, I; Kapranou, A; Giannopoulou, I; Markaki, S; Keramopoulos, A

PPARγ expression in breast cancer:: clinical value and correlation with ERβ

HISTOPATHOLOGY

IF4.1

2005-01-14

PREAI

Papadaki, I; Mylona, E; Giannopoulou, I; Markaki, S; Keramopoulos, A; Nakopoulou, L

Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancer -: art. no. 61

BMC CANCER

IF3.4

2004-09-07

OAAI

Belogianni, I; Apessos, A; Mihalatos, M; Razi, E; Labropoulos, S; Petounis, A; Gaki, V; Keramopoulos, A; Pandis, N; Kyriacou, K; Hadjisavvas, A; Kosmidis, P; Yannoukakos, D; Nasioulas, G

Bone mineral density in young active females: The case of dancers

INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM

IF2.6

2004-06-01

PREAI

Yannakoulia, M; Keramopoulos, A; Matalas, AL

Stromelysin-3 protein expression in invasive breast cancer: Relation to proliferation, cell survival and patients' outcome

MODERN PATHOLOGY

IF5.5

2002-11-01

OAAI

Nakopoulou, L; Panayotopoulou, EG; Giannopoulou, I; Alexandrou, P; Katsarou, S; Athanassiadou, P; Keramopoulos, A

Correlation of tissue inhibitor of metalloproteinase-2 with proliferative activity and patients' survival in breast cancer

MODERN PATHOLOGY

IF5.5

2002-01-01

OAAI

Nakopoulou, L; Katsarou, S; Giannopoulou, I; Alexandrou, P; Tsirmpa, I; Panayotopoulou, E; Mavrommatis, J; Keramopoulos, A

DNA topoisomerase II-alpha immunoreactivity as a marker of tumor aggressiveness in invasive breast cancer

PATHOBIOLOGY

IF2

2001-02-05

PREAI

Nakopoulou, L; Lazaris, A; Kavantzas, N; Alexandrou, P; Athanassiadou, P; Keramopoulos, A; Davaris, P

Scintimammographic findings of in situ ductal breast carcinoma in a double-phase study with Tc-99m(V) DMSA and Tc-99m MIBI value of Tc-99m(V) DMSA

CLINICAL NUCLEAR MEDICINE

IF9.6

2000-06-01

PREAI

Papantoniou, V; Sotiropoulou, M; Stipsaneli, E; Louvrou, A; Feda, H; Christodoulidou, J; Pampouras, G; Zerva, C; Keramopoulos, A; Michalas, S

Sequential administration of paclitaxel and doxorubicin followed by CMF in women with advanced breast cancer

EUROPEAN JOURNAL OF CANCER

IF7.1

1998-09-01

PREAI

Papadimitriou, C; Dimopoulos, M; Lazaris, D; Ampela, C; Louvrou-Fertaki, A; Athanassiades, P; Stamatelopoulos, S; Keramopoulos, A

First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): A phase II study conducted by the Hellenic Cooperative Oncology Group

ANNALS OF ONCOLOGY

IF65.4

1998-09-01

PREAI

Fountzilas, G; Dimopoulos, AM; Papadimitriou, C; Kalogera-Fountzila, A; Aravantinos, G; Bafaloakos, D; Athanassiades, A; Nicolaides, C; Keramopoulos, A; Pavlidis, N; Kosmidis, P; Skarlos, D

研究方向